Biobanking Industry Research Report 2024

Biobanking Industry Research Report 2024


Summary

Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
According to APO Research, The global Biobanking market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Biobanking is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Biobanking include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries and Brooks Life Science, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking.
The Biobanking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biobanking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Biobanking segment by Type

Equipment
Consumable
Biobanking Segment by Application

Virtual Biobanks
Tissue Biobanks
Population Biobanks
Biobanking Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biobanking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Biobanking by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Equipment
2.2.3 Consumable
2.3 Biobanking by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Virtual Biobanks
2.3.3 Tissue Biobanks
2.3.4 Population Biobanks
2.4 Assumptions and Limitations
3 Biobanking Breakdown Data by Type
3.1 Global Biobanking Historic Market Size by Type (2019-2024)
3.2 Global Biobanking Forecasted Market Size by Type (2025-2030)
4 Biobanking Breakdown Data by Application
4.1 Global Biobanking Historic Market Size by Application (2019-2024)
4.2 Global Biobanking Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Biobanking Market Perspective (2019-2030)
5.2 Global Biobanking Growth Trends by Region
5.2.1 Global Biobanking Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Biobanking Historic Market Size by Region (2019-2024)
5.2.3 Biobanking Forecasted Market Size by Region (2025-2030)
5.3 Biobanking Market Dynamics
5.3.1 Biobanking Industry Trends
5.3.2 Biobanking Market Drivers
5.3.3 Biobanking Market Challenges
5.3.4 Biobanking Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Biobanking Players by Revenue
6.1.1 Global Top Biobanking Players by Revenue (2019-2024)
6.1.2 Global Biobanking Revenue Market Share by Players (2019-2024)
6.2 Global Biobanking Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Biobanking Head office and Area Served
6.4 Global Biobanking Players, Product Type & Application
6.5 Global Biobanking Players, Date of Enter into This Industry
6.6 Global Biobanking Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Biobanking Market Size (2019-2030)
7.2 North America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Biobanking Market Size by Country (2019-2024)
7.4 North America Biobanking Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Biobanking Market Size (2019-2030)
8.2 Europe Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Biobanking Market Size by Country (2019-2024)
8.4 Europe Biobanking Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Biobanking Market Size (2019-2030)
9.2 Asia-Pacific Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Biobanking Market Size by Country (2019-2024)
9.4 Asia-Pacific Biobanking Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Biobanking Market Size (2019-2030)
10.2 Latin America Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Biobanking Market Size by Country (2019-2024)
10.4 Latin America Biobanking Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Biobanking Market Size (2019-2030)
11.2 Middle East & Africa Biobanking Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Biobanking Market Size by Country (2019-2024)
11.4 Middle East & Africa Biobanking Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 Thermo Fisher
12.1.1 Thermo Fisher Company Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Revenue in Biobanking Business (2019-2024)
12.1.4 Thermo Fisher Biobanking Product Portfolio
12.1.5 Thermo Fisher Recent Developments
12.2 Beckman Coulter
12.2.1 Beckman Coulter Company Information
12.2.2 Beckman Coulter Business Overview
12.2.3 Beckman Coulter Revenue in Biobanking Business (2019-2024)
12.2.4 Beckman Coulter Biobanking Product Portfolio
12.2.5 Beckman Coulter Recent Developments
12.3 Panasonic
12.3.1 Panasonic Company Information
12.3.2 Panasonic Business Overview
12.3.3 Panasonic Revenue in Biobanking Business (2019-2024)
12.3.4 Panasonic Biobanking Product Portfolio
12.3.5 Panasonic Recent Developments
12.4 SOL Group
12.4.1 SOL Group Company Information
12.4.2 SOL Group Business Overview
12.4.3 SOL Group Revenue in Biobanking Business (2019-2024)
12.4.4 SOL Group Biobanking Product Portfolio
12.4.5 SOL Group Recent Developments
12.5 Promega
12.5.1 Promega Company Information
12.5.2 Promega Business Overview
12.5.3 Promega Revenue in Biobanking Business (2019-2024)
12.5.4 Promega Biobanking Product Portfolio
12.5.5 Promega Recent Developments
12.6 Merck
12.6.1 Merck Company Information
12.6.2 Merck Business Overview
12.6.3 Merck Revenue in Biobanking Business (2019-2024)
12.6.4 Merck Biobanking Product Portfolio
12.6.5 Merck Recent Developments
12.7 Greiner Bio One
12.7.1 Greiner Bio One Company Information
12.7.2 Greiner Bio One Business Overview
12.7.3 Greiner Bio One Revenue in Biobanking Business (2019-2024)
12.7.4 Greiner Bio One Biobanking Product Portfolio
12.7.5 Greiner Bio One Recent Developments
12.8 Chart Industries
12.8.1 Chart Industries Company Information
12.8.2 Chart Industries Business Overview
12.8.3 Chart Industries Revenue in Biobanking Business (2019-2024)
12.8.4 Chart Industries Biobanking Product Portfolio
12.8.5 Chart Industries Recent Developments
12.9 Brooks Life Science
12.9.1 Brooks Life Science Company Information
12.9.2 Brooks Life Science Business Overview
12.9.3 Brooks Life Science Revenue in Biobanking Business (2019-2024)
12.9.4 Brooks Life Science Biobanking Product Portfolio
12.9.5 Brooks Life Science Recent Developments
12.10 Tecan Group
12.10.1 Tecan Group Company Information
12.10.2 Tecan Group Business Overview
12.10.3 Tecan Group Revenue in Biobanking Business (2019-2024)
12.10.4 Tecan Group Biobanking Product Portfolio
12.10.5 Tecan Group Recent Developments
12.11 QIAGEN
12.11.1 QIAGEN Company Information
12.11.2 QIAGEN Business Overview
12.11.3 QIAGEN Revenue in Biobanking Business (2019-2024)
12.11.4 QIAGEN Biobanking Product Portfolio
12.11.5 QIAGEN Recent Developments
12.12 BD
12.12.1 BD Company Information
12.12.2 BD Business Overview
12.12.3 BD Revenue in Biobanking Business (2019-2024)
12.12.4 BD Biobanking Product Portfolio
12.12.5 BD Recent Developments
12.13 Lifeline Scientific
12.13.1 Lifeline Scientific Company Information
12.13.2 Lifeline Scientific Business Overview
12.13.3 Lifeline Scientific Revenue in Biobanking Business (2019-2024)
12.13.4 Lifeline Scientific Biobanking Product Portfolio
12.13.5 Lifeline Scientific Recent Developments
12.14 Hamilton
12.14.1 Hamilton Company Information
12.14.2 Hamilton Business Overview
12.14.3 Hamilton Revenue in Biobanking Business (2019-2024)
12.14.4 Hamilton Biobanking Product Portfolio
12.14.5 Hamilton Recent Developments
12.15 So-Low
12.15.1 So-Low Company Information
12.15.2 So-Low Business Overview
12.15.3 So-Low Revenue in Biobanking Business (2019-2024)
12.15.4 So-Low Biobanking Product Portfolio
12.15.5 So-Low Recent Developments
12.16 TTP Labtech Ltd
12.16.1 TTP Labtech Ltd Company Information
12.16.2 TTP Labtech Ltd Business Overview
12.16.3 TTP Labtech Ltd Revenue in Biobanking Business (2019-2024)
12.16.4 TTP Labtech Ltd Biobanking Product Portfolio
12.16.5 TTP Labtech Ltd Recent Developments
12.17 Biolife Solutions
12.17.1 Biolife Solutions Company Information
12.17.2 Biolife Solutions Business Overview
12.17.3 Biolife Solutions Revenue in Biobanking Business (2019-2024)
12.17.4 Biolife Solutions Biobanking Product Portfolio
12.17.5 Biolife Solutions Recent Developments
12.18 DNA Genotek
12.18.1 DNA Genotek Company Information
12.18.2 DNA Genotek Business Overview
12.18.3 DNA Genotek Revenue in Biobanking Business (2019-2024)
12.18.4 DNA Genotek Biobanking Product Portfolio
12.18.5 DNA Genotek Recent Developments
12.19 Custom Biogenic Systems
12.19.1 Custom Biogenic Systems Company Information
12.19.2 Custom Biogenic Systems Business Overview
12.19.3 Custom Biogenic Systems Revenue in Biobanking Business (2019-2024)
12.19.4 Custom Biogenic Systems Biobanking Product Portfolio
12.19.5 Custom Biogenic Systems Recent Developments
12.20 LVL Technologies
12.20.1 LVL Technologies Company Information
12.20.2 LVL Technologies Business Overview
12.20.3 LVL Technologies Revenue in Biobanking Business (2019-2024)
12.20.4 LVL Technologies Biobanking Product Portfolio
12.20.5 LVL Technologies Recent Developments
12.21 BioRep
12.21.1 BioRep Company Information
12.21.2 BioRep Business Overview
12.21.3 BioRep Revenue in Biobanking Business (2019-2024)
12.21.4 BioRep Biobanking Product Portfolio
12.21.5 BioRep Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings